Product Description
Product Name: Rucaparib Tablets
Strength: 200 mg
Form: Oral Tablet
Category: Anticancer / PARP Inhibitor
Indication: Ovarian Cancer, Prostate Cancer
Rucaparib 200 mg Tablets is an oral targeted therapy used in the treatment of advanced ovarian and prostate cancers, particularly in patients with specific genetic mutations such as BRCA1/2. It belongs to a class of drugs known as PARP (poly ADP-ribose polymerase) inhibitors.
